These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

962 related articles for article (PubMed ID: 8907770)

  • 1. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programmes.
    Richardson G; Linkins RW; Eames MA; Wood DJ; Campbell PJ; Ankers E; Deniel M; Kabbaj A; Magrath DI; Minor PD
    Bull World Health Organ; 1995; 73(6):769-77. PubMed ID: 8907770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies.
    Mas Lago P; Ramon Bravo J; Andrus JK; Comellas MM; Galindo MA; de Quadros CA; Bell E
    Bull World Health Organ; 1994; 72(2):221-5. PubMed ID: 8205641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine.
    Taffs RE; Enterline JC; Rusmil K; Muhilal ; Suwardi SS; Rustama D; Djatnika ; Cobra C; Semba RD; Cohen N; Asher DM
    Bull World Health Organ; 1999; 77(6):484-91. PubMed ID: 10427933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparison of the effectiveness of mass immunization campaign of trivalent oral poliovirus vaccine (TOPV) by epidemiological serosurvey. Shandong Collaborating Group for Poliomyelitis Control and Surveillance, Jinan, Shandong].
    Xu A
    Zhonghua Liu Xing Bing Xue Za Zhi; 1992 Oct; 13(5):261-4. PubMed ID: 1338626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass vaccination campaigns to eradicate poliomyelitis in Madagascar: oral poliovirus vaccine increased immunity of children who missed routine programme.
    Andrianarivelo MR; Boisier P; Rabarijaona L; Ratsitorahina M; Migliani R; Zeller H
    Trop Med Int Health; 2001 Dec; 6(12):1032-9. PubMed ID: 11737841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of house-to-house versus fixed-site oral poliovirus vaccine delivery strategies in a mass immunization campaign in Egypt.
    Linkins RW; Mansour E; Wassif O; Hassan MH; Patriarca PA
    Bull World Health Organ; 1995; 73(5):589-95. PubMed ID: 8846484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan.
    Reichler MR; Kharabsheh S; Rhodes P; Otoum H; Bloch S; Majid MA; Pallansch MA; Patriarca PA; Cochi SL
    J Infect Dis; 1997 Feb; 175 Suppl 1():S198-204. PubMed ID: 9203717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of vaccine-associated paralytic poliomyelitis in Latin America, 1989-91.
    Andrus JK; Strebel PM; de Quadros CA; Olivé JM
    Bull World Health Organ; 1995; 73(1):33-40. PubMed ID: 7704923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anomalous observations on IPV and OPV vaccination.
    John TJ
    Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant use of the oral pentavalent human-bovine reassortant rotavirus vaccine and oral poliovirus vaccine.
    Ciarlet M; Sani-Grosso R; Yuan G; Liu GF; Heaton PM; Gottesdiener KM; Arredondo JL; Schödel F
    Pediatr Infect Dis J; 2008 Oct; 27(10):874-80. PubMed ID: 18756184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of efficacy of a live oral poliovirus vaccine for virulent Sabin-like poliovirus 1 strains in Japan.
    Iwai M; Nakayama T; Matsuura K; Hasegawa S; Ando S; Obara M; Nagai Y; Yoshida H; Horie H
    Acta Virol; 2006; 50(2):139-43. PubMed ID: 16808333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population immunity to polioviruses among preschool children from four urban underserved low income communities, United States, 1997-2001.
    Prevots DR; Pascual FB; Angellili ML; Brayden R; Irigoyen M; Larussa P; Sawyer M; Baughman AL; Pallansch MA
    Pediatr Infect Dis J; 2004 Dec; 23(12):1130-6. PubMed ID: 15626951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eradication of poliomyelitis in Cuba: a historical perspective.
    Más Lago P
    Bull World Health Organ; 1999; 77(8):681-7. PubMed ID: 10516790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children.
    Samoilovich E; Roivainen M; Titov LP; Hovi T
    J Med Virol; 2003 Oct; 71(2):274-80. PubMed ID: 12938203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress towards the global eradication of poliomyelitis.
    Hull HF; Ward NA
    World Health Stat Q; 1992; 45(2-3):280-4. PubMed ID: 1462662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral poliovaccine: will it help eradicate polio or cause the next epidemic?
    Shulman LM; Manor Y; Sofer D; Swartz T; Mendelson E
    Isr Med Assoc J; 2006 May; 8(5):312-5. PubMed ID: 16805227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2001 serological survey in the Czech Republic--poliomyelitis.
    Matyásová I; Rainetová P; Cástková J
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of inactivated poliomyelitis vaccine for primary vaccination].
    Li CG; Ying ZF; Wang JF; Fang HH; Li YP; Li RC; Bonnet MC; Zhang YP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2009 Jun; 43(6):501-3. PubMed ID: 19950717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
    Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
    Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial of a supplemental dose of four poliovirus vaccines.
    Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
    N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.